March 18, 2021 —
Dr. Collins and All of Us Research Program CEO Josh Denny highlight seven major opportunities for accelerating tailored medicine in order to create a more equitable health landscape. Cell. Online: March 18, 2021
March 5, 2021 —
Dr. Collins speaks to Government Executive’s Courtney Bublé on a range of topics including COVID-19 vaccine development, post-acute sequelae of coronavirus (long-COVID), NIH workforce morale during the pandemic, and NIH’s commitment to end structural racism and racial inequities in biomedical research through a new initiative called UNITE.
February 4, 2021 —
TIME’s Belinda Luscombe profiles Dr. Collins, featuring his efforts to speed the development of therapeutics, vaccines, and diagnostics for COVID-19. Noting that he is a respected leader who receives bipartisan support, the profile also recognize his efforts to address and improve health disparities, and his ability to bring together the science and faith communities. TIME. Online: February 4, 2021.
January 2, 2021 —
Drs. Collins, Doudna, Lander, and Rotimi reflect on the advances made in the field of molecular genetics and genomics in recognition of the National Academy of Medicine’s 50th anniversary. New England Journal of Medicine. Online: January 2, 2021.
December 23, 2020 —
Dr. Collins shares that despite long hours which have impacted his work life balance, the COVID-19 pandemic demonstrated to him that scientists from different sectors collaborating towards a common goal can get things done quickly and effectively.
December 15, 2020 —
The Guardian’s Ian Sample examines the COVID-19 pandemic from the genetic sequencing of the virus to the treatments and vaccines available less than a year later and how the pandemic has changed science and global collaboration. The Guardian. Online: December 15, 2020.
December 12, 2020 —
Dr. Collins remarks on COVID-19 vaccine skepticism and hesitancy that is specific to faith communities and ways faith leaders can provide guidance. Washington Post. Online: December 12, 2020.
August 11, 2020 —
In a JAMA Viewpoint, Dr. Collins and Associate Director for Science Policy and Chief of Staff Dr. Carrie Wolinetz urge the scientific community to take concrete action to establish a Henrietta Lacks biospecimen consent policy that would require consent from research participants regardless of whether their biospecimens are identifiable. JAMA. Online: August 11, 2020.